Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Multicenter Single-arm Study of BKM120 Plus Capecitabine for Breast Cancer Patients With Brain Metastases

NCT02000882 is registered in ClinicalTrials.gov with US Oncology Research as lead sponsor.

NCT NCT02000882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02000882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Multicenter Single-arm Study of BKM120 Plus Capecitabine for Breast Cancer Patients With Brain Metastases
Lead sponsor
US Oncology Research
Phase
Phase 2
Overall status
Completed
Start date
May 29, 2014
Completion date
March 29, 2019
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases, breast cancer, metastatic breast cancer